InvestorsHub Logo
Followers 9
Posts 486
Boards Moderated 0
Alias Born 06/23/2017

Re: None

Thursday, 06/30/2022 1:23:25 PM

Thursday, June 30, 2022 1:23:25 PM

Post# of 426436
Here's another "BAD NEWS" headline just came in Fidelity

'New analysis of Amarin's $AMRN Vascepa resurrects big questions about effectiveness' - Tweet By Adam Feuerstein


Just the headine and no detail followed
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News